Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Atossa Therapeutics Q2 Earnings

  Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM.

Here’s what investors need to know about the announcement.

Earnings

Atossa Therapeutics beat estimated earnings by 16.67%, reporting an EPS of $-0.05 versus an estimate of $-0.06.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.56% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Atossa Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Investor Optimism Improves Further After Dow Rises For 11th Straight Session

By Lisa Levin
July 25, 1:38 AM
The CNN Money Fear and Greed index showed further improvement in overall sentiment among U.S. investors on Monday. The Dow Jones moved higher on Monday, recording its longest winning streak since Feb. 2017 ahead of major policy decision from the U.S. Federal Reserve. The index notched gains for the eleventh straight session.

DPZ